Point mutations in the pfcrt and pfmdr-1 genes of Plasmodium falciparum and clinical response to chloroquine, among malaria patients from Nigeria.
about
Identification of a mutant PfCRT-mediated chloroquine tolerance phenotype in Plasmodium falciparumFactors contributing to delay in parasite clearance in uncomplicated falciparum malaria in children.Can pharmacogenomics improve malaria drug policy?Rapid detection of lactate dehydrogenase and genotyping of Plasmodium falciparum in saliva of children with acute uncomplicated malariaEfficacy of artemisinin-based combination treatments of uncomplicated falciparum malaria in under-five-year-old Nigerian children.Therapeutic efficacies of artemisinin-based combination therapies in Nigerian children with uncomplicated falciparum malaria during five years of adoption as first-line treatments.Early variations in plasmodium falciparum dynamics in Nigerian children after treatment with two artemisinin-based combinations: implications on delayed parasite clearance.In vitro amodiaquine resistance and its association with mutations in pfcrt and pfmdr1 genes of Plasmodium falciparum isolates from NigeriaRapid detection of Pfcrt and Pfmdr1 mutations in Plasmodium falciparum isolates by FRET and in vivo response to chloroquine among children from Osogbo, Nigeria.Genetic diversity of Plasmodium falciparum field isolates from south western Nigeria.A qualitative study of the feasibility and community perception on the effectiveness of artemether-lumefantrine use in the context of home management of malaria in south-west Nigeria.Plasmodium falciparum gametocyte sex ratios in children with acute, symptomatic, uncomplicated infections treated with amodiaquine.A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria.Population structure of Plasmodium falciparum gametocyte sex ratios in malarious children in an endemic area.Chloroquine Resistant Plasmodium falciparum in Nigeria: Relationship between pfcrt and pfmdr1 Polymorphisms, In-Vitro Resistance and Treatment Outcome.Malaria hidden in a patient with diffuse large-B-cell lymphoma and sickle-cell traitOpen randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children.Predictors of the failure of treatment with chloroquine in children with acute, uncomplicated, Plasmodium falciparum malaria, in an area with high and increasing incidences of chloroquine resistance.Open randomized study of pyrimethamine-sulphadoxine vs. pyrimethamine-sulphadoxine plus probenecid for the treatment of uncomplicated Plasmodium falciparum malaria in children.A critical role for PfCRT K76T in Plasmodium falciparum verapamil-reversible chloroquine resistance.Plasmodium falciparum gametocyte carriage, sex ratios and asexual parasite rates in Nigerian children before and after a treatment protocol policy change instituting the use of artemisinin-based combination therapies.Selection of Plasmodium falciparum multidrug resistance gene 1 alleles in asexual stages and gametocytes by artemether-lumefantrine in Nigerian children with uncomplicated falciparum malaria.Imported and autochthonous malaria in West Saudi Arabia: results from a reference hospitalPrevalence, risk factors, and antimalarial resistance patterns of falciparum plasmodiasis among pregnant women in Kaduna metropolis, Nigeria
P2860
Q28473923-94ECAB69-919D-4055-AE95-BF7D032FE57EQ33711891-61B5520F-011A-4FCA-9CDF-4DA33C3586C4Q34029396-354531D5-2243-46F5-B6AC-9B6E1417B249Q34087300-D6FA05EE-A6E6-49E1-94F5-2608FB229822Q34496205-C205CD09-3EE6-4DDC-A6B5-093394EB450DQ35031900-F9CD266B-D918-4CA6-A3BF-DD9D1375F7DEQ35154559-6CC52135-5427-44E4-843F-47031F892781Q35545461-15DCC815-33DD-4D5E-B551-6019609A652DQ35757491-641D4E38-1B7A-4ED4-9100-47A79C918FAFQ36569751-C2A7E302-D21F-422C-8257-65137E186E2EQ36724458-AA4114BA-CA82-44C8-BE12-3852D1730953Q36889810-0F36107C-A748-49E9-82DE-1B392AAAB7A4Q37190605-6BC02124-2E8D-4D0A-8E37-8FC26B485BE1Q37434808-AE08CA19-F9F7-4338-8747-E5357937E946Q37445582-30A00314-3BD0-479F-B562-78A5FC753163Q39665329-55B26982-BFD1-41A4-B4F6-E67A61F37D51Q40494997-23CC1260-85D9-4BF2-B1A1-15D3CB062BFAQ40498935-154986B5-796D-4D0E-A605-04E34217A8F7Q40534758-5ACDA783-D19F-4323-B138-BCF519122801Q41912137-4568B087-2637-49AF-BADA-6D8B2B648198Q41931436-7024C793-7A32-4AF2-8839-D7883EF78B1CQ41940547-545C1EB2-8F33-41B0-9044-8347A7223C1DQ56346419-C4F66028-AD07-475C-A24E-4B22238DDDF4Q56440823-B9165BD3-07D6-4885-8A6F-6771C68E2E5A
P2860
Point mutations in the pfcrt and pfmdr-1 genes of Plasmodium falciparum and clinical response to chloroquine, among malaria patients from Nigeria.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Point mutations in the pfcrt a ...... malaria patients from Nigeria.
@en
type
label
Point mutations in the pfcrt a ...... malaria patients from Nigeria.
@en
prefLabel
Point mutations in the pfcrt a ...... malaria patients from Nigeria.
@en
P2093
P2860
P921
P1476
Point mutations in the pfcrt a ...... malaria patients from Nigeria.
@en
P2093
Akinboye DO
Gbotosho GO
P2860
P304
P356
10.1179/000349803235002489
P577
2003-07-01T00:00:00Z